OAC1W (n = 301), n (%) | OAC2W (n = 302), n (%) | OA (n = 305), n (%) | |
---|---|---|---|
AE, adverse event; OA, omeprazole 20 mg twice daily and amoxicillin 1 g twice daily and placebo for 2 weeks; OAC1W, omeprazole 20 mg twice daily and amoxicillin 1 g twice daily and clarithromycin 500 mg twice daily for 1 week, followed by omeprazole 20 mg twice daily and placebo for 1 week; OAC2W, omeprazole 20 mg twice daily and amoxicillin 1 g twice daily and clarithromycin 500 g twice daily for 2 weeks. | |||
Patients with AE | 29 (9.6) | 30 (9.9) | 18 (5.9) |
Treatment discontinuation due to AE | 4 (1.3) | 5 (1.7) | 2 (0.7) |